The improvement of aqueous chemical stability of a model basic drug by ion pairing with acid groups of polyelectrolytes
Carbomer (C) and procaine (P) were selected respectively as models of polyelectrolyte (PE) and basic drug (B) of low stability in aqueous solution. The purpose of this investigation was to test if a (C–P) aqueous system provides a microenvironment in which P is less exposed to hydroxyl ion catalyzed...
Saved in:
Published in | International journal of pharmaceutics Vol. 269; no. 1; pp. 149 - 156 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
09.01.2004
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Carbomer (C) and procaine (P) were selected respectively as models of polyelectrolyte (PE) and basic drug (B) of low stability in aqueous solution. The purpose of this investigation was to test if a (C–P) aqueous system provides a microenvironment in which P is less exposed to hydroxyl ion catalyzed degradation, its main degradation pathway over a wide pH range. It was determined that in (C–P) a high fraction of P was present in the form of ion pairs [RCOO
−PH
+] with the carboxylate groups of C. The [RCOO
−PH
+] fraction was above 97% for compositions containing higher than 50
mol% of P. The chemical stability of C–P was assayed at two selected pHs (7.5 and 8.5) in comparison with conventional reference solutions (RS) without C. Procaine in (C–P) was 4.2 and 6.2 times more stable than in its respective RS at the two conditions assayed. The stabilizing factor was calculated as the ratio of the rate constants
k
obs
RS/
k
obs
C–P.
Since C–B systems exhibit negative electrokinetic potential that attracts positive ions such as (H
+) and repels negative ones such as (OH
−), the stabilizing effect would be associated with the higher acidity of (C–P) environment, in which PH
+ molecules attached to the PE should also have lower kinetic energy than those in the bulk medium. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0378-5173 1873-3476 |
DOI: | 10.1016/j.ijpharm.2003.09.008 |